Director, RaaS Research Group, Research as a Service (RaaS)

RaaS Research Group (RaaS)

Director, RaaS Research Group

Insightful Financial Models and Research Analysis

Research as a Service (RaaS)

Connect to the right investors through smart and insightful financial models and research analysis.

Equity Bottom-Up

<div>
<div>
<div>
<div>
<h2>Chrysos Corporation Ltd</h2>
<h3>Delivering faster, more accurate gold analysis</h3>
<div>
<div>
<div>
<div>
<p>Chrysos Corporation Ltd (ASX:C79) is a rapidly growing provider of assay services to the global mining industry through its exclusive ownership of the CSIRO-developed PhotonAssayTM technology. PhotonAssayTM is a quantitative, chemical-free assay solution which can be used to detect a wide-range of elements and is particularly effective for gold. It displaces the centuries-old process of fire assay which involves the use of extreme heat, chemical re-agents, and human intervention. Fire assay is destructive to the ore and produces toxic waste in the process. In contrast, PhotonAssayTM uses high-energy X-rays to activate the elements in mineral samples and from the emitted gamma radiation measures the amount of metal in the sample. The process is non-destructive, allowing samples to be retained for re-testing, uses less energy and has proven to be more accurate particularly in the context of complex mineralogy. Chrysos listed on the ASX on 6 May 2022, raising $183.5m at $6.50/share. The IPO provided a realisation event for some early-stage investors and raised $65m in new capital for the company’s growth plans. CSIRO remains the company’s largest shareholder with a 22% stake. The company counts as clients major testing, inspection and certification laboratories, whose own customers include some of the world’s biggest miners such as Barrick Gold and Agnico Eagle.</p>
<div>
<div>
<div>
<div>
<h3>Business model</h3>
<p>The Chrysos PhotonAssayTM units are typically leased on a five-year basis, with a five-year option to extend. The company outsources much of the manufacturing and assembly, plus a portion of the unit maintenance to specialist global security manufacturer, Nuctech. Chrysos retains full oversight and responsibility for the assembly of the system “smarts” to ensure protection of its IP. The lease agreements work on a minimum monthly assay payment which essentially sets a specified rate per assay multiplied by a minimum utilisation each month. Customers pay for any additional assays above the minimum commitment. The units are leased by miners and independent laboratories around the world. As at 11 August, the company had more than $705m in total contract value committed via 48 lease contracts. The company estimates there are more than 600 laboratories around the world analysing ore samples for the metals sector and these represent Chrysos’ market opportunity.</p>
<h3>FY22 results beat prospectus forecasts</h3>
<p>Chrsysos reported its first results to the market and beat prospectus with FY22 proforma EBITDA of $1.45m. Prospectus forecast for FY22 EBITDA was $0.925m. FY22 reported revenue of $14.3m was 3.8% up on the prospectus forecast for $13.7m. The company noted in its FY22 presentation that it was on track to meet its FY23 prospectus target for revenue of $26.6m and EBITDA of $3.2m.</p>
<h3>Look to peers which deliver ESG solutions to miners</h3>
<p>We would look to peers which deliver ESG solutions to mining companies. ASX-listed ESG mining software group K2fly (ASX:K2F) also services the larger mining companies with long- term enterprise contracts for its technology and reports TCV.</p>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>





Chrysos Corporation Ltd
Delivering faster, more accurate gold analysis




Chrysos Corporation Ltd (ASX:C79) is a rapidly growing provider of assay services to the global mining industry through its exclusive ownership of the CSIRO-developed PhotonAssayTM technology. PhotonAssayTM is a quantitative, chemical-free assay solution which can be used to detect a wide-range of elements and is particularly effective for gold. It displaces the centuries-old process of fire assay which involves the use of extreme heat, chemical re-agents, and human intervention. Fire assay is destructive to the ore and produces toxic waste in the process. In contrast, PhotonAssayTM uses high-energy X-rays to activate the elements in mineral samples and from the emitted gamma radiation measures the amount of metal in the sample. The process is non-destructive, allowing samples to be retained for re-testing, uses less energy and has proven to be more accurate particularly in the context of complex mineralogy. Chrysos listed on the ASX on 6 May 2022, raising $183.5m at $6.50/share. The IPO provided a realisation event for some early-stage investors and raised $65m in new capital for the company’s growth plans. CSIRO remains the company’s largest shareholder with a 22% stake. The company counts as clients major testing, inspection and certification laboratories, whose own customers include some of the world’s biggest miners such as Barrick Gold and Agnico Eagle.




Business model
The Chrysos PhotonAssayTM units are typically leased on a five-year basis, with a five-year option to extend. The company outsources much of the manufacturing and assembly, plus a portion of the unit maintenance to specialist global security manufacturer, Nuctech. Chrysos retains full oversight and responsibility for the assembly of the system “smarts” to ensure protection of its IP. The lease agreements work on a minimum monthly assay payment which essentially sets a specified rate per assay multiplied by a minimum utilisation each month. Customers pay for any additional assays above the minimum commitment. The units are leased by miners and independent laboratories around the world. As at 11 August, the company had more than $705m in total contract value committed via 48 lease contracts. The company estimates there are more than 600 laboratories around the world analysing ore samples for the metals sector and these represent Chrysos’ market opportunity.
FY22 results beat prospectus forecasts
Chrsysos reported its first results to the market and beat prospectus with FY22 proforma EBITDA of $1.45m. Prospectus forecast for FY22 EBITDA was $0.925m. FY22 reported revenue of $14.3m was 3.8% up on the prospectus forecast for $13.7m. The company noted in its FY22 presentation that it was on track to meet its FY23 prospectus target for revenue of $26.6m and EBITDA of $3.2m.
Look to peers which deliver ESG solutions to miners
We would look to peers which deliver ESG solutions to mining companies. ASX-listed ESG mining software group K2fly (ASX:K2F) also services the larger mining companies with long- term enterprise contracts for its technology and reports TCV.













Chrysos Corporation Ltd - Delivering Faster, More Accurate Gold Analysis

Australia

Chrysos Corporation Limited provides software solutions. The Company combines science and software to create technology solutions for the global mining industry. Chrysos serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Chrysos Corporation (C79 AU)

Chrysos Corporation Ltd - Delivering Faster, More Accurate Gold Analysis

Chrysos Corporation Ltd Delivering faster, more accurate gold analysis Chrysos Corporation Ltd (ASX:C79) is a rapidly growing provider of...

Research as a Service (RaaS)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)